Search Results - "PICHON, Sylvie" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

by Bernstein, David I, Munoz, Flor M, Callahan, S. Todd, Rupp, Richard, Wootton, Susan H, Edwards, Kathryn M, Turley, Christine B, Stanberry, Lawrence R, Patel, Shital M, Mcneal, Monica M, Pichon, Sylvie, Amegashie, Cyrille, Bellamy, Abbie R
Published in Vaccine (12.01.2016)

Get full text

Journal Article

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

by Griffiths, Paul D, Prof, Stanton, Anna, RN, McCarrell, Erin, MSc, Smith, Colette, PhD, Osman, Mohamed, PhD, Harber, Mark, FRCP, Davenport, Andrew, FRCP, Jones, Gareth, MRCP, Wheeler, David C, FRCP, O'Beirne, James, MRCP, Thorburn, Douglas, FRCP, Patch, David, FRCP, Atkinson, Claire E, MSc, Pichon, Sylvie, MSc, Sweny, Paul, FRCP, Lanzman, Marisa, MRPharmS, Woodford, Elizabeth, Rothwell, Emily, RGN, Old, Natasha, BA, Kinyanjui, Ruth, RN, Haque, Tanzina, FRCPath, Atabani, Sowsan, MRCPath, Luck, Suzanne, MBChB, Prideaux, Steven, BSc, Milne, Richard SB, PhD, Emery, Vincent C, Prof, Burroughs, Andrew K, Prof
Published in The Lancet (British edition) (09.04.2011)

Get full text

Journal Article

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults

by Pichon, Sylvie, Guinet-Morlot, Francoise, Saleh, Jamshid, Essink, Brandon, Pineda-Peña, Andrea-Clemencia, Moureau, Annick, Petit, Celine, Minutello, Ada-Maria
Published in Human vaccines & immunotherapeutics (15.12.2023)

Get full text

Journal Article

Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation

Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation

by Baraniak, Ilona, Gomes, Ariane C., Sodi, Isabella, Langstone, Toby, Rothwell, Emily, Atkinson, Claire, Pichon, Sylvie, Piras-Douce, Fabienne, Griffiths, Paul D., Reeves, Matthew B.
Published in EBioMedicine (01.12.2019)

Get full text

Journal Article

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study

by Quiambao, Beatriz, Montalban, Cecilia, Minutello, Ada-Maria, Guinet-Morlot, Françoise, Moureau, Annick, Petit, Celine, Pichon, Sylvie
Published in Vaccine (19.08.2022)

Get full text

Journal Article

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

by Sabbaj, Steffanie, Pass, Robert F., Pichon, Sylvie, Goepfert, Paul A.
Published in The Journal of infectious diseases (01.06.2011)

Get full text

Journal Article

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies

by Baraniak, Ilona, Kropff, Barbara, Ambrose, Lyn, McIntosh, Megan, McLean, Gary R., Pichon, Sylvie, Atkinson, Claire, Milne, Richard S. B., Mach, Michael, Griffiths, Paul D., Reeves, Matthew B.
Published in Proceedings of the National Academy of Sciences - PNAS (12.06.2018)

Get full text

Journal Article

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults

by Pichon, Sylvie, Moureau, Annick, Petit, Celine, Kirstein, Judith L., Sheldon, Eric, Guinet-Morlot, Francoise, Minutello, Ada-Maria
Published in Vaccine (11.04.2024)

Get full text

Journal Article

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phase II pre-exposure prophylaxis regimen study

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phase II pre-exposure prophylaxis regimen study

by Quiambao, Beatriz, Montalban, Cecilia, Minutello, Ada-Maria, Guinet-Morlot, Françoise, Moureau, Annick, Petit, Celine, Pichon, Sylvie
Published in Vaccine (19.08.2022)

Get full text

Journal Article

Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial

Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial

by Pineda-Peña, Andrea-Clemencia, Jiang, Qian, Petit, Celine, Korejwo-Peyramond, Joanna, Donazzolo, Yves, Latreille, Mathilde, Homery, Marie-Claude, Babin, Valerie, Benamor, Sonia, Pichon, Sylvie, Guinet-Morlot, Françoise, Minutello, Ada-Maria
Published in Clinical infectious diseases (14.06.2024)

Get full text

Journal Article

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia

by Baraniak, Ilona, Kropff, Barbara, McLean, Gary R, Pichon, Sylvie, Piras-Douce, Fabienne, Milne, Richard S B, Smith, Colette, Mach, Michael, Griffiths, Paul D, Reeves, Matthew B
Published in The Journal of infectious diseases (25.05.2018)

Get full text

Journal Article

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study

by Pichon, Sylvie, Moureau, Annick, Petit, Celine, Chu, L., Essink, B., Muse, D., Saleh, J., Guinet-Morlot, Françoise, Minutello, Ada-Maria
Published in Vaccine (05.08.2022)

Get full text

Journal Article

An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults

An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults

by Levie, Karin, Leroux-Roels, Isabel, Hoppenbrouwers, Karel, Kervyn, Anne-Diane, Vandermeulen, Corinne, Forgus, Sheron, Leroux-Roels, Geert, Pichon, Sylvie, Kusters, Inca
Published in The Journal of infectious diseases (01.09.2008)

Get full text

Journal Article

A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab™ for pre-exposure use in healthy adults: Results from a randomized controlled phase-II trial

A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab™ for pre-exposure use in healthy adults: Results from a randomized controlled phase-II trial

by Pichon, Sylvie, Guinet-Morlot, Françoise, Minutello, Maria, Donazzolo, Yves, Rouzier, Regine, Chassard, Didier, Fitoussi, Serge, Hou, Victor
Published in Vaccine (26.04.2013)

Get full text

Journal Article

인간 시토메갈로바이러스 면역원성 조성물

인간 시토메갈로바이러스 면역원성 조성물

by PIRAS DOUCE FABIENNE, CHAUX PASCAL, DUMAS RAFAELA, HAENSLER JEAN, PICHON SYLVIE
Year of Publication 13.05.2020

Get full text

Patent

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China

by Li, Rongcheng, Huang, Lirong, Li, Jia, Mo, Zhaojun, He, Bin, Wang, Yunpeng, Wu, Xiaohong, Minutello, Maria, Guinet-Morlot, Françoise, Pichon, Sylvie
Published in Vaccine (05.12.2013)

Get full text

Journal Article

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab registered when administered according to a post-exposure regimen in healthy children and adults in China

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab registered when administered according to a post-exposure regimen in healthy children and adults in China

by Li, Rongcheng, Huang, Lirong, Li, Jia, Mo, Zhaojun, He, Bin, Wang, Yunpeng, Wu, Xiaohong, Minutello, Maria, Guinet-Morlot, Francoise, Pichon, Sylvie
Published in Vaccine (01.12.2013)

Get full text

Journal Article

1113Safety and Efficacy of a Cytomegalovirus Glycoprotein B (gB) Vaccine in Adolescent Girls

1113Safety and Efficacy of a Cytomegalovirus Glycoprotein B (gB) Vaccine in Adolescent Girls

by Bernstein, David I., Callahan, S. Todd, Munoz-Rivas, Flor, Rupp, Rick, Edwards, Kathryn, Stanberry, Lawrence R., Pichon, Sylvie, Amegashie, Cyrille, Bellamy, Abbie R.
Published in Open forum infectious diseases (01.12.2014)

Get full text

Journal Article

Protecting Stem Cell Transplant Recipients Against CMV Reactivation by Vaccinating Their Donors with a Canarypox pp65 Vaccine (ALVAC)

Protecting Stem Cell Transplant Recipients Against CMV Reactivation by Vaccinating Their Donors with a Canarypox pp65 Vaccine (ALVAC)

by Shenoy, Aarthi G., Solomon, Scott R., Pichon, Sylvie, Cadoz, Michel, Nancy, Hensel, Barrett, A. John
Published in Blood (16.11.2006)

Get full text

Journal Article

An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. Commentary

An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. Commentary

by POLAND, Gregory A, SAMBHARA, Suryaprakash, KUSTERS, Inca, LEVIE, Karin, LEROUX-ROELS, Isabel, HOPPENBROUWERS, Karel, KERVYN, Anne-Diane, VANDERMEULEN, Corinne, FORGUS, Sheron, LEROUX-ROELS, Geert, PICHON, Sylvie
Published in The Journal of infectious diseases (2008)

Get full text

Journal Article